2,5-Dimethoxy-4-methylphenylcyclopropylamine
Names | |
---|---|
Preferred IUPAC name 2-(2,5-Dimethoxy-4-methylphenyl)cyclopropan-1-amine | |
Identifiers | |
| |
3D model (JSmol) | |
ChEMBL | |
ChemSpider |
|
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
| |
| |
Properties | |
C12H17NO2 | |
Molar mass | 207.273 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
Chemical compound
2,5-Dimethoxy-4-methylphenylcyclopropylamine (DMCPA) is a lesser-known psychedelic drug and a substituted amphetamine. DMCPA was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 15–20 mg and the duration is listed as 4–8 hours.[1] DMCPA produces open-eye visuals, anorexia, and psychedelic dreams. Shulgin gives it a +++ on the Shulgin Rating Scale.
Legality
[edit]United Kingdom
[edit]This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]
Pharmacology
[edit]Very little data exists about the pharmacological properties, metabolism, and toxicity of DMCPA.
See also
[edit]References
[edit]- ^ DMCPA Entry in PiHKAL
- ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.
Phenethylamines |
|
---|---|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
Retrieved from "https://en.wikipedia.org/w/index.php?title=2,5-Dimethoxy-4-methylphenylcyclopropylamine&oldid=1160101674"